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ABSTRAK (BAHASA MALAYSIA) 
 
Latar belakang: Endometriosis adalah salah satu penyakit ginekologi yang paling 
lazim dialami oleh kaum wanita dalam lingkungan umur produktif. Sehingga kini, 
pendiagnosaan penyakit ini dibuat melalui pembedahan, dengan melihat rupa bentuk 
tisu, serta dipastikan melalui ujian histopatologi tisu terlibat. Memandangkan ramai 
pesakit yang tidak mahu menjalani pembedahan untuk pendiagnosaan penyakit ini, 
diagnosa yang tepat dan rawatan yang sewajarnya tidak dapat dibuat. Baru baru ini, 
sekumpulan penyelidik dari Hospital Universiti Sains Malaysia telah membuat satu 
sistem skor yang diberi nama CliEndomet, yang tidak memerlukan pembedahan 
untuk pendiagnosaan endometriosis. Sistem skor ini didapati setanding dengan 
diagnosa endometriosis yang dibuat melalui pembedahan. Walau bagaimanapun, 
perbandingan tersebut dibuat tanpa pengesahan ujian histopatologi. Kesahihan sistem 
skor tersebut akan menjadi lebih jitu jika perbandingan dengan histopatologi dapat 
dilakukan.  
Objektif: Kajian ini adalah bertujuan untuk mengkaji ketepatan CliEndomet sebagai 
alat diagnosa endometriosis berbanding dengan pendiagnosaan secara pembedahan 
dan histologi tisu.  
Metodologi: Seramai 94 pesakit yang mempunyai tanda penyakit endometriosis 
seperti sakit sengugut, dan sakit pada ruang pelvis telah menyertai kajian ini. Mereka 
telah menjalani pemeriksaan abdomen dan pelvis, ujian ultrasound dan darah mereka 
telah diambil untuk ujian CA-125. Data-data mereka telah dimasukkan ke dalam 
sistem skor CliEndomet dan kemungkinan setiap pesakit untuk menghidap 
endometriosis telah diambilkira. Pesakit-pesakit kemudiannya menjalani 
pembedahan di mana tisu mereka telah diambil untuk ujian histologi. Seandainya 
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mereka dijangkakan mempunyai endometriosis semasa dalam pembedahan, mereka 
akan digolongkan kepada peringkat penyakit berdasarkan revised American Society 
for Reproductive Medicine (ASRM) system. Pesakit hanya disahkan mempunyai 
endometriosis sekiranya ujian histologi mengesahkan diagnosa tersebut. Kesahihan 
skor diagnosis CliEndomet dikenalpasti dengan mengambil kira sensitiviti, 
spesifisiti, positive predictive ratio (PPV), negative predictive ratio (NPV), 
likelihood ratio positive (LR +), likelihood ratio negative (LR-) dan ujian Kappa 
coefficient, yang dibandingkan dengan diagnosa melalui histologi.  
Keputusan: Seramai 94 pesakit telah menyertai kajian ini. Seramai 56 pesakit telah 
disahkan mempunyai endometriosis melalui kaedah ujian histologi, manakala 50 
pesakit didapati berisiko tinggi mempunyai endometriosis melalui kaedah penskoran 
CliEndomet. Kepekaan, kekhususan, PPV, NPV, LR + dan LR - of CliEndomet 
adalah 69.6%, 71.1%, 78.0%, 61.4%, 2.41 dan 0.43. Mereka juga bersetuju adil 
antara CliEndomet dan diagnosis endometriosis berdasarkan pengesahan histologi, κ 
= 0.397 (95% CI, 0,21-0,58), p <0.005. Melalui kaedah pemerhatian semasa 
pembedahan, 62 orang pesakit telah didapati mempunyai endometriosis. Dengan 
menggunakan penskoran CliEndomet, lima orang pesakit di dalam kumpulan 
endometriosis peringkat awal telah didapati berisiko rendah dan 12 orang pesakit 
berisiko tinggi mempunyai endometriosis. Di kalangan mereka yang mempunyai 
risiko tinggi melalui kaedah CliEndomet, hanya dua orang pesakit mempunyai 
endometriosis peringkat awal dan 43 orang pesakit mempunyai endometriosis 
peringkat tinggi. CliEndomet telah didapati berkesan untuk diagnosa endometriosis 
peringkat tinggi berbanding peringkat awal, dengan spesifikasi 78% dan negative 
predictive value 96%, berbanding peringkat awal yang hanya mempunyai sensitiviti 
71% dan positive predictive value 29%. 
x 
Kesimpulan: CliEndomet didapati boleh membantu dalam mendiagnosis 
endometriosis, bagi pesakit-pesakit yang tidak mahu menjalani pembedahan untuk 
pendiagnosaan yang lebih tepat. Keupayaan CliEndomet untuk berbuat demikian 
adalah lebih ketara untuk mereka yang mempunyai endometriosis peringkat tinggi.  
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ABSTRACT (ENGLISH) 
 
Background: Endometriosis is one of the most common gynaecological disorders 
affecting the reproductive age group of women. The current gold standard in 
diagnosing this disease is via direct visualisation of endometriosis lesion 
intraoperatively and followed histological confirmation. Detection of non-invasive 
test is one of the priorities in endometriosis research. CliEndomet which was 
formulated by a group of researchers in Hospital Universiti Sains Malaysia using 
clinical manifestations, ultrasound findings and serum CA-125 had shown to be in 
substantial agreement with the intraoperative findings of endometriosis, but there is a 
need to validate the accuracy and reliability of CliEndomet using a more objective 
method i.e. histology confirmation. 
Objectives: The main objective of this study is to assess the accuracy of CliEndomet 
in the diagnosis of endometriosis with histopathology as the confirmation. It also 
serves to determine the accuracy of CliEndomet in staging the severity of 
endometriosis. 
Methodology: This was a cross sectional study that involving 94 patients who 
presented with symptoms of dysmenorrhea and chronic pelvic pain suggestive of 
endometriosis. Data regarding the symptoms, physical examination, scan findings 
and serum CA-125 were obtained preoperatively and scoring done according to 
CliEndomet into high possibility and low possibility group. Patients were then 
subjected to operation accordingly and the intraoperative findings were obtained 
regarding presence of endometriotic lesion. If endometriosis was clinically 
diagnosed, the disease was staged according to the revised American Society for 
Reproductive Medicine (ASRM) staging system. Regardless of the presence of 
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typical endometriotic lesion, tissue biopsy was taken during the operation for 
histopathology confirmation. The sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV), positive likelihood ratio (PPV) , 
negative likelihood ratio (NPV), likelihood ratio positive (LR +) and likelihood ratio 
negative (LR-). The reliability for the diagnosis of endometriosis using CliEndomet 
was tested using Kappa coefficient. 
Results: A total of 94 patients were recruited into this study. Of the 94 patients, 56 
were confirmed to have endometriosis by histology examination, and 50 were noted 
to have high risk for endometriosis using the CliEndomet scoring system. 
CliEndomet was shown to be 69.6% sensitive to diagnose endometriosis with 
positive predictive value of 78%. It has 71.1% of specificity and 61.4% negative 
predictive value. Its positive likelihood ratio was 2.41 and negative likelihood ratio 
of 0.43. CliEndomet was shown to have a fair agreement in diagnosing 
endometriosis (κ = 0,397 (95% CI, 0,21-0,58), p <0.005). During the surgery, 62 
patients were found to have endometriosis. These patients were classified into having 
early stage endometriosis (AFS scoring system: minimal and mild endometriosis), 
and advanced stage disease (AFS scoring system: moderate and severe 
endometriosis). Of those who have early stage endometriosis, 5 patients had low risk 
and 2 had high risk of endometriosis according to the CliEndomet scoring system. 
Among those in the advanced stage disease, 12 patients were scored as low risk and 
43 were scored as high risk. The sensitivity of CliEndomet to detect early stage 
endometriosis was 42% with positive predictive value of 29%. It is more capable to 
detect advanced stage disease (specificity 78%, negative predictive value of 96%).  
xiii 
Conclusions: CliEndomet has a role to diagnose endometriosis in patients who 
refuse invasive diagnostic method. It is more accurate to predict the existence of 
advanced disease then early stage disease.  
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1.0 INTRODUCTION 
Endometriosis is a common gynaecological condition affecting about 6-10% of 
women of reproductive age and can be a debilitating disease. It is the second most 
common reason for surgery in premenopausal women. It is defined as the presence 
of endometrial-like tissue outside the uterus, which induces a chronic, inflammatory 
like reaction (S et al., 2005). The presentation of endometriosis varies, being 
abdominal or pelvic pain remains as the commonest presentation. However, the 
severity of the pain does not correlate well with the extent of the disease. On the 
other hand, these symptoms mimic a lot of other diseases such as pelvic 
inflammatory disease and irritable bowel syndrome. Because of the non-specific 
presentation and clinical findings, diagnosis of endometriosis remains a challenge to 
clinicians over the centuries. 
The use of blood investigations for various tumour markers and various imaging 
techniques has been evaluated to diagnose endometriosis. However, to date, no 
individual serum marker has been found to be specific to endometriosis (Hsu et al., 
2010). Combination of six biomarkers has been reported with good sensitivity and 
acceptable specificity even for minimal to mild disease (Mihalyi et al., 2010). 
Unfortunately, the exorbitant cost of these tumour markers prohibits its usage in our 
community.  
In 2014, the European Society of Human Reproduction and Embryology (ESHRE) 
has stated that combination of laparoscopy and histological verification of 
endometrial glands and/ or stroma is considered the gold standard for diagnosis of 
the disease (Dunselman et al., 2014). Despite this guideline, it was found that there 
was a wide variety in the inter observer accuracy in the visual diagnosis of 
endometriosis in the same patient (Buchweitz et al., 2005). As at present there is no 
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other better diagnostic tool for endometriosis, this method remains to be the gold 
standard diagnostic tool for endometriosis. It means that for every patient in whom 
endometriosis is suspected clinically, an operation either by laparotomy or 
laparoscopic surgery for direct visualization of the lesion appearance, with 
histopathologic confirmation is required. At the current worldwide economic 
downturn, this management will cause an escalation to the medical cost and be a 
burden to many patients. In addition, many patients will be reluctant to undergo such 
an invasive procedure. 
Because of the above problems, a consensus workshop, convened following the tenth 
world congress of endometriosis, had recommended that detection of a non-invasive 
diagnostic test is one of the priorities in endometriosis research (Rogers et al., 2013). 
The development of a non-invasive diagnostic test for endometriosis would have a 
ground breaking impact on the patients’ quality of life, on the efficacy of available 
treatment as well as on the cost of endometriosis  (Mihalyi et al., 2010). By having 
endometriosis to be diagnosed early, this will indirectly improve the outcome of 
infertility treatment which is associated with endometriosis.  
1.1 THE CLIENDOMET 
In 2014, a non-invasive diagnostic tool for endometriosis, named as CliEndomet, 
was created by a group of USM researchers. The objective of this yet to be published 
study was to find a non-invasive diagnostic tool for endometriosis, which include the 
combination of clinical presentation (chronic pelvic pain), pelvic assessment, 
ultrasonic assessment and the level of serum CA-125 (Pang SC et al, 2014). 
In that study, all patients who presented to the Gynaecology Clinic of Hospital USM 
(Hospital USM), with any form of pelvic pain were recruited. A thorough history and 
physical examination which include pelvic examination was performed. The serum 
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CA-125 was taken and all patients had to undergo diagnostic operation either by 
laparoscopy or laparotomy to visualize the presence of endometriotic lesion. In the 
presence of endometriotic lesion, the stage of the disease was done in accordance to 
the revised America’s Fertility Staging System.  
A simple logistic regression test was then performed to evaluate the significant 
parameters which present among the patients diagnosed with endometriosis during 
the operation. From the analysis, significant variables were identified and later 
analysed using the multiple logistic regression test, which could predict the presence 
of endometriosis. It was noted that the presence of dysmenorrhoea, ovarian mass and 
serum CA-125 between 50 to 200u/ml were significantly associated with 
endometriosis. With those findings, a scoring system, which was named as 
CliEndomet (as shown in Figure 1), was formulated and was tested for its reliability 
to diagnose endometriosis. In that study, it was noted that CliEndomet carried a 
substantial agreement with direct visualisation of lesion for the diagnosis of 
endometriosis (kappa 0.77). 
Even though direct visualisation of endometriotic tissue is considered as the gold 
standard diagnostic tool for endometriosis, when it comes to the development of a 
new diagnostic tool, the comparison should be made with an objective diagnostic 
tool, that is the histology of the biopsied tissue, thus the main aim of this study.  
4 
 
CliEndomet 
The Diagnostic Clinical Scoring System For 
Endometriosis 
 
 
Registration no:  ……………………… Date: ………………………………………… 
Criteria Score 
Dysmenorrhoea : 
 No dysmenorrhoea 
 Mild dysmenorrhoea 
 Moderate dysmenorrhoea 
 Severe dysmenorrhoea 
 
0 
1 
2 
3 
Ultrasonographic findings : 
 Solid ovarian mass or cystic with papillary projections 
 Uniloculated, serous ovarian cyst 
 Multiloculated cyst with thick sedimentations (ground-glass 
appearance ) 
 
0 
1 
2 
Level of  serum CA-125 : 
 < 50 U/mL or > 200 U/mL 
 50 – 200 U/mL 
 
0 
2 
 
Total score = (dysmenorrhoea + ultrasonographic findings + CA-125) x 2 
                   =  ………………….. 
Risk of having endometriosis: 
Total score Possibility of endometriosis 
Score 0 – 2 Unlikely  
Score 4 – 6 Low possibility 
Score 8 – 10 Moderate possibility 
Score 12 - 14 High possibility 
  
 
 
 
Figure 1: The CliEndomet Scoring System 
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1.2 STUDY JUSTIFICATION 
The diagnosis of endometriosis in the previous study  had led into the formulation of 
CliEndomet (Pang et al, 2014)  Even though this new non-invasive scoring system 
was proved to be reliable to predict the presence of endometriosis, the comparison 
was made with the intraoperative findings, which was surgeon’s dependant. It is very 
important to be certain of the accuracy of this diagnostic tool, as when wrong 
diagnosis is made, the management given for the patient will be affected. 
To further analyse the accuracy of the CliEndomet, an objective method of 
diagnostic tool, i.e. by histopathology examination of the lesion found during the 
operation, is needed. As tissue biosy was not taken in all patients in the previous 
study, comparison with this objective method could not be done in the same cohort 
of patients, thus the need of this study to be performed. 
The methodology of the current study was same as in the previous study, except that 
tissue biopsy was done for all patients, regardless of the presence of typical 
endometriotic lesion.  
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2.0 LITERATURE REVIEW  
A long delay in diagnosis of endometriosis has been reported in several studies due 
to the non-specific presentation of the disease: an overall diagnostic delay of 10 
years in Germany and Austria, 8 years in the UK and Spain, 7 years in Norway, 7-10 
years in Italy and 4-5 years in Ireland and Belgium (Ballard et al., 2006; Nnoaham et 
al., 2011) Considerable diagnostic delay of up to 8 years from presenting symptoms 
often confers a heavy economic and social price (Ballard et al., 2006). 
Traditionally, patients with endometriosis usually presented with cyclical pain and 
infertility although chronic pelvic pain, deep dyspareunia, cyclical intestinal 
complaints and fatigue are also common presentation. The ESHRE recommended 
that clinicians should consider the diagnosis of endometriosis in the presence of 
gynaecological symptoms, which include dysmenorrhea, non-cyclical pelvic pain, 
deep dyspareunia, infertility and fatigue, and non-gynaecological symptoms like 
dyschezia, dysuria, hematuria and rectal bleeding and shoulder pain in women of 
reproductive age (Dunselman et al., 2014). 
Specific symptoms have been reported to occur more frequently in women with 
endometriosis when compared to the control group (Ballard et al., 2008). In a cohort 
study of women with chronic pelvic pain, women with endometriosis are more likely 
to report their pain as throbbing and experience dyschezia, in comparison with 
women with an apparently normal pelvis (Ballard et al., 2010). However, the 
severity of endometriosis does not always correspond to the pain intensity. In a study 
conducted in Indonesia, the most frequent symptoms in patient with endometriosis 
was infertility (77.8%), which was followed by dysmenorrhea (62.5%), dyspareunia 
(35%) and chronic pelvic pain, which only consist of 27.5% (Hadisaputra, 2013).  
These symptoms could predict the stage III and stage IV endometriosis with good 
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accuracy, but very poor in diagnosing the early staged disease (Nnoaham et al., 
2012). 
The presence of thickening of the uterosacral ligaments, and nodularity of the 
vagina, rectovaginal space and Pouch of Douglas found during the pelvic 
examination may indicate the presence of endometriosis (Bazot et al., 2009; Hudelist 
et al., 2009). 
Several imaging methods, such as transvaginal ultrasonography (TVUS), transrectal 
ultrasonography (TRUS), computed topography scan (CT scan) and magnetic 
resonance imaging (MRI) have been used in an attempt to improve the non-invasive 
diagnosis of endometriosis. However, due to its inadequate resolution to identify 
adhesions or superficial peritoneal implants of endometriosis, its usage is rather 
limited (Hsu et al., 2010). 
TVUS has been proposed as the first line-line imaging technique because it allows 
extensive exploration of the pelvis. It is well accepted and widely available (Bazot et 
al., 2009; Exacoustos et al., 2014). Few literatures have supported that 
endometrioma can be diagnosed accurately by TVUS (Hsu et al., 2010; Somigliana 
et al., 2010; Van Holsbeke et al., 2010). However, its value for the assessment of 
superﬁcial peritoneal lesions, ovarian foci, and deeply infiltrating endometriosis is 
questionable (Lo Monte et al., 2014)  The inclusion of TVUS-based soft markers in 
women with symptoms suggestive of endometriosis improves the ability to predict or 
exclude the presence of endometriosis (Said and Azzam, 2013). Investigations on the 
use of three dimensional (3D) ultrasonography in area of rectovaginal septum, 
rectosigmoid and deep infiltrating disease have shown promising results (Abrao et 
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al., 2007; Grasso et al., 2010; Pascual et al., 2010). However, its accuracy is not well 
established (Dunselman et al., 2014). 
MRI is mostly used as a second line imaging modality for endometriosis. Although 
the accuracy is proven to be more superior to TVUS (Abdel Maboud Ibrahim and 
Elsaeed, 2012; Bazot et al., 2009), the significant cost differential between MRI and 
TVUS makes MRI more useful only for ultrasonographically-indeterminate pelvic 
mass (Hsu et al., 2010). 
A considerable effort has been invested in searching for non-invasive methods of 
diagnosis of endometriosis. Various serum, peritoneal fluid and tissue markers are 
reported to be associated with endometriosis. Among those biomarkers that received 
more research attention than others are Cancer antigen 125 (CA-125), vascular 
endothelial growth factor (VEGF) and several interleukins such as IL-6 and IL-8 
(Bedaiwy and Falcone, 2004; Elgafor El Sharkwy, 2013; Foda and Aal, 2012; Hirata 
et al., 2011; Kitawaki et al., 2005; Ozhan et al., 2014; Ramos et al., 2012; Socolov et 
al., 2011). Unfortunately, until now the proposed markers have not shown to be 
effective in their diagnostic value due to their inconsistency that change with age, 
menstrual cycle and the fluctuant level in early stage of the disease (Socolov et al., 
2011). Combined use of potential biomarkers has been proposed to increase the 
sensitivity and specificity of the tumour markers in diagnosing endometriosis even in 
mild to moderate stage of the disease (May, Conduit-Hulbert et al, 2010; Mihalyi, 
Gevaert et al., 2010; Vodolazkaia, El-Aalamat et al, 2012; Ozhan, Kokcu et al., 
2014). However, its accuracy and reliability is yet to be proven clinically. 
Endometrial nerve fibers in the endometrium of women with endometriosis were 
analysed and being explored for diagnosis. Using endometrial biopsy for the 
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diagnosis was possible on the basis of the fact that multiple small unmyelinated 
sensory nerve fibers have found in the functional layer of ectopic endometrium in all 
women with endometriosis (Tokushige et al., 2007). However some evidences 
suggest that endometriosis patients on hormonal treatment also have fewer nerve 
fibers compared to endometriosis patients who are not on hormones. Therefore this 
method was not useful unless combined use with other non-invasive method such as 
IL-6 (Elgafor El Sharkwy, 2013). 
The gold standard for diagnosis of endometriosis remains inspection of the 
abdominal cavity and histological demonstration of lesions using laparoscopy or 
laparotomy (Dunselman et al., 2014). However, performing any surgery is not 
without risk. There are also personal and institutional financial consequences 
attached to any surgery as well as the potential anxiety for women undergoing the 
procedure. Furthermore laparoscopic visualisation of endometriosis does not always 
correlate with the histopathologic diagnosis, especially for deep seated endometriosis 
(Wanyonyi et al., 2011). 
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3.0 GENERAL OBJECTIVE 
To assess the accuracy of CliEndomet as a reliable tool in the diagnosis of 
endometriosis 
3.1 SPECIFIC OBJECTIVES: 
1. To determine the reliability of CliEndomet in the diagnosis of endometriosis, 
with histopathology diagnosis as the comparison 
2. To determine the accuracy or validity of CliEndomet in staging the severity 
of endometriosis 
 
3.2 RESEARCH HYPOTHESIS 
The CliEndomet is a reliable and accurate non-invasive diagnostic tool to diagnose 
any stage of endometriosis. 
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4.0 METHODOLOGY  
4.1 STUDY DESIGN, LOCATION AND PERIOD OF STUDY 
This is a cross sectional study with a goal to validate the accuracy of 
CliEndomet to diagnose endometriosis. The study was conducted in 
Hospital USM, for 12 months, from 1st October 2015 until 30th September 
2016. This study consisted of patients who presented with pelvic pain. 
4.2 REFERENCE POPULATION 
      Patients who have dysmenorrhea and chronic pelvic pain in Kelantan. 
4.3 SOURCE POPULATION AND SAMPLING FRAME 
Patients with chronic pelvic pain presented at Gynaecology clinic    
Hospital USM, Kelantan. 
4.4 INCLUSION AND EXCLUSION CRITERIA 
4.4.1 Inclusion criteria 
1. Age between 18 to 45 years old, as endometriosis is common to occur in 
this reproductive age group. 
2. Presented with any form of chronic pelvic pain, such as dysmenorrhoea, 
dyspareunia or dyschezia. 
3. Ever have sexual intercourse, as pelvic examination which comprises of 
bimanual vaginal examination is part of the patient’s assessment.  
4.4.2 Exclusion criteria 
1. Patients who have been confirmed to have endometriosis prior to study 
recruitment  
2. Patients who have been ‘empirically’ treated as endometriosis prior to 
study recruitment 
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3. Patients who had pelvic pain which were already confirmed to be caused 
by other disorders such as pelvic inflammatory disease, varices or genital 
malformation 
4. Patients with psychiatric problems 
4.5 SAMPLE SIZE CALCULATION  
The sample size was calculated using single proportion formula as below: 
n= (
𝑧
∆
)2 p (1-p)  
Anticipated population proportion (p) = 59%  (Pang SC et al , 2014) 
Level of significance    = 0.05 
Absolute precision    = 0.1  
n = (
1.96
0.1
)
2
 0.59𝑥 (1 − 0.59) 
   = 93 
For the sample size of sensitivity and specificity is as below based on the 
calculation by Dr. Lin Naing @ Mohd. Ayub Sadiq from the website 
http://www.kck.usm.my/ppsg/statistical_resources/samplesize_forsensitivity_
specificitystudiesLinNaing.xls and previous phase I study by Pang SC et al, 
2014. 
Expected sensitivity of 87.4%                   
Expected specificity of 90.4%  
Expected prevalence of 47% 
With desired precision of 0.1 at 95% confidence level, 94 subjects were 
recruited into the study. 
As 10% drop out rate was anticipated therefore, a total of 103 (94 + 9) 
patients were required at the analysis stage. 
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4.6 STUDY METHOD 
Patients presented with dysmenorrhea and chronic pelvic pain, who attended 
the Gynaecology Clinic of Hospital USM, fulfilled the inclusion and 
exclusion criteria, were recruited, using the convenience sampling. The 
consent to participate in the study was obtained from the selected patients. 
The study was not blinded to any parties. 
In accordance to the standard procedure, all patients with any type of 
abdominal or pelvic pain were clinically assessed (via history taking and 
pelvic examination), had a transvaginal ultrasound performed, blood for 
Ca125 level taken and be subjected to operation (either laparoscopic or 
laparotomy), to obtain tissue for histology examination. 
Dysmenorrhoea is defined as having cyclical abdominal pain one or two days 
prior to the onset of menses, lasted at any time during or throughout the 
menses. 
Chronic pelvic pain refers to any form of pelvic pain (dyspareunia/ ovulation 
pain/ dyschezia/ non-specific pelvic pain) of more than 6 months’ duration 
that has significant effect on daily function and quality of life.  
A questionnaire was developed to determine the intensity of pain and severity 
of the disease The dysmenorrhoea and pelvic pain were evaluated using a 
modified version of Andersch and Milsom’s multidimensional verbal rating 
scale (Koninckx PR , 1996), which defines pain according to the limitation of 
the ability to work (unaffected=0; rarely affected=1; moderately affected=2; 
clearly inhibited=3), co-existing of systemic symptoms (absent=0; present=1) 
and the need for analgesics (no=0; rarely=1; regularly=2; inefficacious=3). 
The score for each symptom was summed up and ranked into three groups as 
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mild, moderate and severe. Score 1-3 was considered as mild, 4 and 5 as 
moderate and 6 and 7 were ranked as severe.   
The severity of deep dyspareunia and non- specific pelvic pain was evaluated 
using a 10- point linear analogue scale in which 0 indicated no pain and 10 as 
unbearable pain. 
In clinical examination, the abdominal and bimanual examination were 
performed to determine the presence of abdominal or adnexa mass. The 
characteristic of the mass was evaluated for tenderness, mobility, margin, 
surface, consistency and the presence of ascites. The size and position of the 
uterus was also being evaluated.  
Ultrasound of the pelvis was performed as transvaginal scan using 
CAPASEE II (Toshiba Otawara, Japan) connected to a 7MHz transducer. 
The size and position of the uterus were evaluated. In the presence of an 
adnexal mass, its size, site, nodularity, natre, content, the presence of septum 
and papillary projection were determined. 
CA-125 is a high molecular weight glycoprotein of epithelial origin found in 
normal cells and which is produced in the celomic epithelium during 
embryonic development.  Pang et al (2014) had demonstrated that serum CA-
125 at the level of 50 to 200u/ml was strongly associated with endometriosis. 
Similarly in this study, blood for CA-125 level was taken prior to the time 
patient was going for operation.  
The data of the patients were entered in the Clinical research Forms, which is 
only assessable to the research team members. 
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At the end of the clinical assessment, the data were collated and the risk of 
endometriosis for the patient will be scored using the CliEndomet scoring 
system, before subjecting the patient for operation. 
Patients then subjected to operation, either by laparoscopic or laparotomy. 
Cystectomy was performed and the cyst wall was sent for histology 
examination should it was noted to be present during the operation. In the 
absence of ovarian tissue or endometriotic lesion, a random tissue biopsy was 
taken for that purpose. Should a typical endometriotic lesion was observed 
during operation, the disease was staged using the revised American Society 
for Reproductive Medicine (ASRM) staging system.  
The reference diagnosis of endometriosis was made based on the findings of 
endometriotic tissue (defined as the presence of ectopic endometrial tissue, 
i.e. glandular and stromal structures) in the histopathology examination.  
4.7 STATISTICAL ANALYSIS 
Data was entered and analysed using SPSS version 22. Descriptive statistics 
were used to summarise the socio demographic characteristics of subjects. 
Numerical data will be presented as mean (SD) or median (IQR) based on 
their normality distribution. Categorical data will be presented as frequency 
(percentage). 
Level of significance is set as 5% and result was presented with 95% 
confidence intervals. The accuracy or validity of CliEndomet was tested by 
determining the sensitivity and specificity of the score, as well as the positive 
predictive and negative predictive value were determined.  
The reliability for the diagnosis of endometriosis using CliEndomet was 
tested using Kappa coefficient. 
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4.8 TERMINOLOGY 
Chronic pelvic pain :  
Any form of pelvic pain (dyspareunia/ ovulation pain/ dyschezia/ non-
specific pelvic pain) of more than 6 months duration that has significant 
effect on daily function and quality of life. 
Dyschezia  
Difficult or painful evacuation of feces from the rectum. 
Dysmenorrhea   
Cyclical abdominal pain one or two days prior to the onset of menses, lasted 
at any time during or throughout the menses 
Dyspareunia 
Persistent or recurrent genital pain that occurs just before, during or after 
intercourse.  
Histopathology   
It is the microscopic study of abnormal tissue and organs at the cellular level. 
Nonspecific pelvic pain  
Abdominal or pelvic pain of less than 7 days duration for which the diagnosis 
remain uncertain after clinical examination and baseline investigations. 
Ovulation pain  
Lower abdominal pain associated with ovulation, about 14 days prior to next 
menstruation 
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Sexual intercourse  
Any penetration of the female sex organ by the male sex organ 
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4.9 FLOW CHART OF STUDY 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients attending Gynaecology clinics HUSM with dysmenorrhea and chronic pain 
Inclusion criteria 
Exclusion criteria 
Consent 
History taking by assessing pain score using 
modified Andersch & Milsom’s 
multidimentional verbal rating scale 
Physical examination 
Transvaginal ultrasound to detect the presence of ovarian cyst and its 
characteristics 
CliEndomet scoring 
Positive scoring for 
endometriosis 
(Score 8 to 14) 
 
Negative scoring for 
endometriosis 
(Score 0 to 6) 
 
Laparoscopic or laparotomy visualization 
and resection of tissues exhibiting 
endometriotic involvement, followed by 
histological confirmation 
Histopathology 
diagnosis of 
endometriosis 
Histopathology 
diagnosis of non-
endometriosis 
Blood taken to measure for CA-125 level 
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RESULTS 
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5.0 RESULTS 
5.1 DEMOGRAPHIC DATA 
A total of 94 patients were recruited into the study, 56 patients (59.6%) was 
confirmed to have endometriosis by histology examination (Figure 2). 
 
Figure 2: Diagnosis of endometriosis by histology examination 
 
The age of the patients ranged from 19 to 45 years old, with mean age of 32.87 ± 
7.25 years (Table 1). 
Majority of the patients were Malay (96.8%). 
Majority of the patients fell in the category of overweight and obese, contributing 
34.04% (n= 32) and 22.34% (n=21) respectively. Only 30.85% (n=29) of them had 
normal BMI. Eight patients (8.51%) were noted to be underweight and one (1.06%) 
was noted to be morbidly obese. The mean BMI of the patients was 26.33 ± 5.61 
kg/m2.  
56, 60%
38, 40%
HPE DIAGNOSIS OF ENDOMETRIOSIS
Endometriosis
No Endometriosis
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More than half of the patients (n=55, 58.5%) had subfertility. The mean duration of 
subfertility was 8.12 ± 6.00 years. The mean parity for those with a child or children 
was 1.07 ± 1.72. 
The demographic data of the patients was summarised as in Table 1. 
The demographic data of the patients was compared between endometriotic patients 
and non-endometriotic patients. The demographic data were noted to be well 
distributed among the two groups, as shown in Table 2. 
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Table 1: Demographic data 
Variables 
Frequency 
(n) 
Percentage 
(%) 
Mean 
Standard 
deviation 
(SD) 
Age (years): 
- ≤ 19.9  
- 20.0-29.9 
- 30.0-39.9 
-  40.0-49.9 
 
2 
35 
32 
25 
 
2.10 
37.20 
34.0 
26.6 
32.87 7.25 
Ethnic group: 
- Malay 
- Chinese 
- Indian 
- Others 
 
91 
1 
0 
2 
 
96.81 
1.06 
0.00 
2.13 
 
  
BMI (kg/m2) 
- < 18.5 
- 18.5-24.9 
- 25.0-29.9 
- 30.0-34.9 
- 35.0-39.9 
- ≥ 40 
 
 
8 
29 
32 
21 
3 
1 
 
8.51 
30.85 
34.04 
22.34 
3.19 
1.06 
26.33 5.61 
Subfertility 
- Present 
- Absent 
 
55 
39 
 
58.51 
41.49 
 
  
Duration of 
subfertility 
(years), n=55 
- 2.0-4.9 
- 5.0-7.9 
- 8.0-10.9 
- ≥ 11 
 
 
 
20 
11 
24 
0 
 
 
 
36.36 
20.00 
43.64 
0.00 
 
8.12 1.72 
Parity 
- 0 
- 1-2 
- 3-4 
- 5-6 
- ≥7 
 
57 
20 
13 
4 
0 
 
60.64 
21.28 
13.83 
4.25 
0.00 
1.07 6.00 
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Table 2: Comparison of demographic data between endometriotic and non-
endometriotic patients 
VARIABLES MEAN b Crude OR 
(95% CI) 
P Value 
Endometriosis 
 
(n= 56) 
No 
endometriosis 
(n=38) 
   
Mean age 
(years) 
32.98 (7.293) 32.71 (7.00) 0.01 1.01  
(0.95-1.06) 
0.863 
BMI (kg/m2) 25.67 (6.07) 27.30 (4.89) -0.052 0.95 
(0.88-1.02) 
0.741 
Parity 0.96 (1.80) 1.24 (1.58) -0.09 0.91 
(0.72-1.16) 
0.835 
Subfertility  
 Present 
 Absent 
 
36 (64.3%) 
20 (35.7%) 
 
19 (50%) 
19 (50%) 
 
0.59 
 
1.80 
(0.78-4.16) 
 
0.169 
Last child 
birth 
3.36 ( 5.92) 4.21 (5.92) -0.02 0.98 
(0.91-1.05) 
0.491 
Years of 
subfertility 
8.13 (6.30) 8.11 (5.56) 0.01 1.00 
(0.91-1.10) 
0.987 
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5.2 DIAGNOSIS OF ENDOMETRIOSIS USING CLIENDOMET 
Using the CliEndomet scoring system, the patients were categorised to be either 
unlikely to have endometriosis, low possibility, moderate possibility, or high likely 
to have endometriosis. Only patients who were in the moderate and high possibility 
to have endometriosis were considered to be positive endometriosis using the 
CliEndomet criteria. 
Table 3 shows the distribution of total score of the patients using the CliEndomet 
scoring system. Most of the subjects fall into the total score of 6 and 8, with 18 
persons in each group, followed by 17 persons with total score of 10. 
Table 3: Distribution of total score using CliEndomet scoring system 
Total Score Frequency (n) Percentage (%) 
0 1 1.1 
2 10 10.6 
4 14 14.9 
6 18 19.1 
8 18 19.1 
10 17 18.1 
12 14 14.9 
14 2 2.1 
Total 94 100.0 
 
The total scores of the patients were grouped into unlikely to have endometriosis (0-
2), low possibility (4-6), moderate (8-10) and high possibility (12-14) to have 
endometriosis, and these possibilities were compared with the histology diagnosis as 
shown in Table 4. 
